Occurrence and Frequency of Arrhythmias in Hypertrophic Cardiomyopathy in Relation to Delayed Enhancement on Cardiovascular Magnetic Resonance

The Use of Contrast-Enhanced Magnetic Resonance Imaging to Identify Reversible Myocardial Dysfunction

Kim, R. J., Wu, E., Rafael, A., Chen, E.-L., Parker, M. A., Simonetti, O. P., Klocke, F. J., Bonow, R. O., & Judd, R. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432003 · Cited by 3,308

Relationship of MRI Delayed Contrast Enhancement to Irreversible Injury, Infarct Age, and Contractile Function

Kim, R. J., Fieno, D. S., Parrish, T. B., Harris, K. R., Chen, E.-L., Simonetti, O. P., Bundy, J. M., Finn, J. P., Klocke, F. J., & Judd, R. M. (1999) · Circulation · doi:10.1161/01.cir.100.19.1992 · Cited by 2,583

Sudden Death in Young Competitive Athletes: Clinical, Demographic, and Pathological Profiles

Maron, B. J. (1996) · JAMA · doi:10.1001/jama.1996.03540030033028 · Cited by 1,693

American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy

Maron, B. J., McKenna, W. J., Danielson, G. K., KAPPENBERGER, L. J., Kuhn, H. J., Seidman, C. E., Shah, P. M., Spencer, W. H., Spirito, P., ten Cate, F. J., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00941-0 · Cited by 1,572

Sudden Death in Young Athletes

Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022783 · Cited by 1,394

Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy

Grothues, F., Smith, G. C., Moon, J. C. C., Bellenger, N. G., Collins, P., Klein, H. U., & Pennell, D. J. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02381-0 · Cited by 1,267

Cardiovascular Magnetic Resonance, Fibrosis, and Prognosis in Dilated Cardiomyopathy

Assomull, R. G., Prasad, S. K., Lyne, J. C., Smith, G., Burman, E., KHAN, M. G., Sheppard, M. N., Poole-Wilson, P. A., & Pennell, D. J. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.049 · Cited by 1,163

Sudden death in hypertrophic cardiomyopathy: identification of high risk patients

Elliot, P. M., Poloniecki, J. D., Dickie, S., Sharma, S., Monserrat, L., Varnava, A. M., Mahon, N., & McKenna, W. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01003-2 · Cited by 976

Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies

Mahrholdt, H., Wagner, A., Judd, R. M., Sechtem, U. P., & Kim, R. J. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi258 · Cited by 914

Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy

Maron, B. J., Shen, W.-K., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Bardy, G. H., Favale, S., Rea, R. F., Boriani, G., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420601 · Cited by 832

Visual estimation of the extent of myocardial hyperenhancement on late gadolinium-enhanced CMR in patients with hypertrophic cardiomyopathy

Doesch, C., Huck, S., Böhm, C. K., Michaely, H. J., Fluechter, S., Haghi, D., Dinter, D. J., Borggrefe, M., & Papavassiliu, T. (2010) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2010.03.034 · Cited by 16

Sudden Cardiac Death Risk Prediction: The Role of Cardiac Magnetic Resonance Imaging

van der Bijl, P., Podlesnikar, T., Bax, J. J., & Delgado, V. (2018) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2018.05.019 · Cited by 16

Predictors of Left Ventricular Dysfunction in Friedreich’s Ataxia in a 16-Year Observational Study

Legrand, L., Diallo, A., Monin, M., Ewenczyk, C., Charles, P., Isnard, R., Vicaut, É., Montalescot, G., Dürr, A., & Pousset, F. (2019) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-019-00375-z · Cited by 16

Cardiac MRI evaluation of nonischemic cardiomyopathies

François, C. J., Schiebler, M. L., & Reeder, S. B. (2010) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22030 · Cited by 16

Phenotypic variation and targeted therapy of hypertrophic cardiomyopathy using genetic animal models

Gannon, M. P., & Link, M. S. (2019) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2019.11.009 · Cited by 13

Relationship Between Obstructive Sleep Apnea and Late Gadolinium Enhancement and Their Effect on Cardiac Arrhythmias in Patients with Hypertrophic Obstructive Cardiomyopathy

Wang, S., Cui, H. Z., Ji, K., Zhu, C., Huang, X., Lai, Y., & Wang, S. (2021) · Nature and Science of Sleep · doi:10.2147/nss.s270684 · Cited by 15

Mitral annular plane systolic excursion is an easy tool for fibrosis detection by late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy

Doesch, C., Sperb, A., Sudarski, S., Loßnitzer, D., Rudic, B., Tülümen, E., Heggemann, F., Schimpf, R., Schoenberg, S. O., Borggrefe, M. M., et al. (2015) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2015.01.010 · Cited by 14

Cardiovascular Magnetic Resonance for Risk Stratification of Arrhythmia in Hypertrophic Cardiomyopathy⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Nazarian, S., & Lima, J. A. C. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.01.010 · Cited by 15

Arrhythmia and Electrophysiological Effects of Chemotherapy: A Review

Markman, T. M., & Nazarian, S. (2016) · Oncology · doi:10.1159/000446374 · Cited by 15

The role of cardiac magnetic resonance imaging in differentiating the underlying causes of left ventricular hypertrophy

Germans, T., Brouwer, W. P., Groothuis, J. G. J., Beek, A. M., Götte, M., & van Rossum, A. C. (2010) · Netherlands Heart Journal · doi:10.1007/bf03091752 · Cited by 15

Cardiovascular Magnetic Resonance in Heart Failure

Karamitsos, T. D., & Neubauer, S. (2011) · Current Cardiology Reports · doi:10.1007/s11886-011-0177-2 · Cited by 15

The Relationship between Cardiac Magnetic Resonance-Assessed Replacement and Interstitial Fibrosis and Ventricular Arrhythmias in Hypertrophic Cardiomyopathy

Karabinowska-Małocha, A., Dziewięcka, E. M., Banyś, P., Urbańczyk‐Zawadzka, M., Krupiński, M., Mielnik, M., Łach, J., Budkiewicz, A., Podolec, P. S., Żydzik, Ł., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020294 · Cited by 14

Myocardial Repolarization Dispersion and Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy

Magrì, D., Cecco, C. N. D., Piccirillo, G., Mastromarino, V., Serdoz, A., Muscogiuri, G., Ricotta, A., Gregori, M., Marino, L., Cauti, F. M., et al. (2014) · Circulation Journal · doi:10.1253/circj.cj-13-1423 · Cited by 14

The Role of Cardiovascular Magnetic Resonance in Sudden Death Risk Stratification in Hypertrophic Cardiomyopathy

Maron, M. S. (2015) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2015.03.003 · Cited by 14

Relationship between Regional Fat Distribution and Hypertrophic Cardiomyopathy Phenotype

Guglielmi, V., Maresca, L., Lanzillo, C., Marinoni, G. M., D’Adamo, M., Roma, M. D., Preziosi, P., Bellia, A., Calò, L., & Sbraccia, P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158892 · Cited by 14

Integrated Imaging in Hypertrophic Cardiomyopathy

Choudhury, L., Rigolin, V. H., & Bonow, R. O. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.09.033 · Cited by 14

ESC sudden‐death risk model in hypertrophic cardiomyopathy: Incremental value of quantitative contrast‐enhanced CMR in intermediate‐risk patients

Hinojar, R., Zamorano, J. L., Gómez, A. G., Martín, M. P., Esteban, A., Rincon, L. M., Portugal, J. C., Nácher, J. J. J., & Fernández‐Golfín, C. (2017) · Clinical Cardiology · doi:10.1002/clc.22735 · Cited by 14

Prediction of Extensive Myocardial Fibrosis in Nonhigh Risk Patients With Hypertrophic Cardiomyopathy

Gommans, D. H. F., Cramer, G. E., Fouraux, M. A., Bakker, J., Michels, M., Dieker, H.-J., Timmermans, J., Marcelis, C., Verheugt, F. W. A., de Boer, M., et al. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.04.020 · Cited by 14

Risk stratification in hypertrophic cardiomyopathy

Marrakchi, S., Kammoun, I., Bennour, E., Laroussi, L., & Kachboura, S. (2018) · Herz · doi:10.1007/s00059-018-4700-8 · Cited by 14

MRI Characteristics, Prevalence, and Outcomes of Hypertrophic Cardiomyopathy with Restrictive Phenotype

Li, S., Wu, B., Yin, G., Song, L., Jiang, Y. L., Huang, J., Zhao, S., & Lu, M. (2020) · Radiology Cardiothoracic Imaging · doi:10.1148/ryct.2020190158 · Cited by 14

Reduced myocardial septal function assessed by cardiac magnetic resonance feature tracking in patients with hypertrophic obstructive cardiomyopathy: associated with histological myocardial fibrosis and ventricular arrhythmias

Song, Y., Bi, X., Chen, L., Yang, K., Chen, X., Dong, Z., Wang, J., Kong, X., Zhao, K., Wang, H., et al. (2022) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeac032 · Cited by 14

The risk of non-sustained ventricular tachycardia after percutaneous alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy

Kłopotowski, M. M., Chojnowska, L., Małek, Ł. A., Mączyńska, R., Kukuła, K., Demkow, M., Witkowski, A., Dąbrowski, M., Karcz, M. A., Baranowski, R., et al. (2010) · Clinical Research in Cardiology · doi:10.1007/s00392-010-0116-z · Cited by 14

Current and future role of cardiovascular magnetic resonance in cardiac resynchronization therapy

Leyva, F., & Foley, P. W. X. (2011) · Heart Failure Reviews · doi:10.1007/s10741-010-9213-3 · Cited by 14

ECG characteristics according to the presence of late gadolinium enhancement on cardiac MRI in hypertrophic cardiomyopathy

Grall, S., Bière, L., Clerfond, G., Mateus, V., Prunier, F., & Furber, A. (2014) · Open Heart · doi:10.1136/openhrt-2014-000101 · Cited by 14

New cardiovascular biomarkers: clinical implications in patients with valvular heart disease

Moura, L. M., Rocha‐Gonçalves, F., Zamorano, J. L., Barros, I. M., Bettencourt, P., & Rajamannan, N. M. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.7.945 · Cited by 14

QRS-T angle in patients with Hypertrophic Cardiomyopathy - A comparison with Cardiac Magnetic Resonance Imaging

Jensen, C. J., Lambers, M., Zadeh, B. S. A., Wambach, J. M., Naßenstein, K., & Bruder, O. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.52415 · Cited by 13

Imaging spectrum of sudden athlete cardiac death

Arrigan, M., Killeen, R. P., Dodd, J. D., & Torreggiani, W. C. (2011) · Clinical Radiology · doi:10.1016/j.crad.2010.10.011 · Cited by 13

2014 Korean Guidelines for Appropriate Utilization of Cardiovascular Magnetic Resonance Imaging: A Joint Report of the Korean Society of Cardiology and the Korean Society of Radiology

Yoon, Y. E., Hong, Y. J., Kim, H., Kim, J. A., Na, J. O., Yang, D. H., Kim, Y. J., & Choi, E. (2014) · Korean Circulation Journal · doi:10.4070/kcj.2014.44.6.359 · Cited by 13

Cardiac Magnetic Resonance Imaging for Stage B Heart Failure

Partington, S. L., Cheng, S. C., & Lima, J. A. C. (2012) · Heart Failure Clinics · doi:10.1016/j.hfc.2011.11.009 · Cited by 13

Predicción del riesgo de muerte súbita cardiaca: el papel de la resonancia magnética cardiaca

van der Bijl, P., Podlesnikar, T., Bax, J. J., & Delgado, V. (2018) · Revista Española de Cardiología · doi:10.1016/j.recesp.2018.04.040 · Cited by 13

The relationship between myocardial fibrosis detected by cardiac magnetic resonance and Tp‐e interval, 5‐year sudden cardiac death risk score in hypertrophic cardiomyopathy patients

Demir, A. R., Çelik, Ö., Sevinç, S., Uygur, B., Kahraman, S., Yılmaz, E., Cemek, M., Önal, Y., & Ertürk, M. (2019) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12672 · Cited by 13

Risk of arrhythmic events after alcohol septal ablation for hypertrophic cardiomyopathy using continuous implantable cardiac monitoring

Bleszynski, P. A., Goldenberg, I., Fernandez, G., Howell, E. H., Younis, A., Chen, A. Y., McNitt, S. A., Bruckel, J., Ling, F. S., Cove, C. J., et al. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.08.013 · Cited by 13

Prevalence, characteristics, and natural history of apical phenotype in a large cohort of patients with hypertrophic cardiomyopathy

Rouskas, P., Zegkos, T., Ntelios, D., Gossios, T. D., Parcharidou, D. G., Papanastasiou, C. A., Karamitsos, T. D., Vassilikos, V., Kouskouras, K., & Efthimiadis, G. K. (2023) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2023.02.004 · Cited by 14

Cardiac MRI evaluation of hypertrophic cardiomyopathy: Left ventricular outflow tract/aortic valve diameter ratio predicts severity of LVOT obstruction

Vogel‐Claussen, J., Tomas, M. S., Newatia, A., Boyce, D. M., Pinheiro, A. C., Abraham, R. M., Abraham, T. P., & Bluemke, D. A. (2012) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23677 · Cited by 13

Extensive Myocardial Fibrosis in a Patient With Hypertrophic Cardiomyopathy and Ventricular Tachycardia Without Traditional High-Risk Features

Bongioanni, S., Spirito, P., Masi, A. S., Chiribiri, A., Bonamini, R., & Conte, M. R. (2009) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.108.824839 · Cited by 13

High Sensitivity of Late Gadolinium Enhancement for Predicting Microscopic Myocardial Scarring in Biopsied Specimens in Hypertrophic Cardiomyopathy

Konno, T., Hayashi, K., Fujino, N., Nagata, Y., Hodatsu, A., Masuta, E., Sakata, K., Nakamura, H., Kawashiri, M., & Yamagishi, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101465 · Cited by 13

Cardiac Magnetic Resonance Imaging and Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy

McKenna, W. J., & Nagueh, S. F. (2014) · Circulation · doi:10.1161/circulationaha.114.010977 · Cited by 13

Imaging to Facilitate Ventricular Tachycardia Ablation

Chery, G. S., Khoshknab, M. P., & Nazarian, S. (2024) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2024.08.003 · Cited by 12

Perspectives on Sudden Death Prevention in Hypertrophic Cardiomyopathy

Efthimiadis, G. K., Zegkos, T., Meditskou, S., & Hadjimiltiades, S. (2014) · Cardiology in Review · doi:10.1097/crd.0000000000000017 · Cited by 12

Recent advances in hypertrophic cardiomyopathy

Yingchoncharoen, T., & Tang, W. H. W. (2014) · F1000Prime Reports · doi:10.12703/p6-12 · Cited by 12

Functional, morphological and electrocardiographical abnormalities in patients with apical hypertrophic cardiomyopathy and apical aneurysm: correlation with cardiac MR

Suwa, K., Satoh, H., Sano, M., Nobuhara, M., Saitoh, T., Saotome, M., Urushida, T., Katoh, H., Tawarahara, K., Ohtani, H., et al. (2014) · Open Heart · doi:10.1136/openhrt-2014-000124 · Cited by 12

Delayed-enhancement MRI of apical hypertrophic cardiomyopathy: assessment of the intramural distribution and comparison with clinical symptoms, ventricular arrhythmias, and cine MRI

Amano, Y., Takayama, M., Fukushima, Y., Kitamura, M., & Kumita, S. (2011) · Acta Radiologica · doi:10.1258/ar.2011.100351 · Cited by 12

Relationship of Nonseptal Late Gadolinium Enhancement to Ventricular Tachyarrhythmia in Hypertrophic Cardiomyopathy

Amano, Y., Yanagisawa, F., Kitamura, M., Tachi, M., & Kumita, S. (2017) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0000000000000599 · Cited by 12

Improving the clinical understanding of hypertrophic cardiomyopathy by combining patient data, machine learning and computer simulations: A case study

Lyon, A., Mincholé, A., Bueno‐Orovio, A., & Rodríguez, B. (2019) · Morphologie · doi:10.1016/j.morpho.2019.09.001 · Cited by 12

Hypertrophic Cardiomyopathy

Bluemke, D. A., & Yang, E. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.05.023 · Cited by 12

Advances in Multi-Modality Imaging in Hypertrophic Cardiomyopathy

Goldie, F. C., Lee, M. M. Y., COATS, C. J., & Nordin, S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13030842 · Cited by 11

Exploring Health Care Disparities in Genetic Testing and Research for Hereditary Cardiomyopathy: Current State and Future Perspectives

Huang, H., Verma, J., Mok, V., Bharadwaj, H. R., Alrawashdeh, M. M., Aratikatla, A., Sudan, S., Talukder, S., Habaka, M., Tse, G., et al. (2024) · Global Medical Genetics · doi:10.1055/s-0044-1779469 · Cited by 15

Quantitative comparison of 2D and 3D late gadolinium enhancement MR imaging in patients with Fabry disease and hypertrophic cardiomyopathy

Morsbach, F., Gordic, S., Gruner, C., Niemann, M., Goetti, R. P., Gotschy, A., Kozerke, S., Alkadhi, H., & Manka, R. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.04.175 · Cited by 11

Ventricular Arrhythmias and Left Ventricular Hypertrophy in Hypertrophic Cardiomyopathy

Mattos, B. P. E., Torres, M. A. R., de Freitas, V. C., Scolari, F. L., & de Loreto, M. S. (2013) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20130078 · Cited by 11

Exercise related ventricular arrhythmias are related to cardiac fibrosis in hypertrophic cardiomyopathy mutation carriers

van Rijsingen, I. A. W., Bekkers, S. C. A. M., Schalla, S. M., Ast, J. F. H.-V., Snoep, G., Alzand, B. S. N., Arens, Y. H. J. M., van den Wijngaard, A., Crijns, H. J. G. M., & Pinto, Y. M. (2011) · Netherlands Heart Journal · doi:10.1007/s12471-011-0090-8 · Cited by 11

Myocardial fibrosis assessed by CMR to predict events in HCM

Marsan, N. A., & Bax, J. J. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.137 · Cited by 11

The relationship between angiotensin converting enzyme gene I/D polymorphism and QT dispersion in patients with hypertrophic cardiomyopathy

Kaya, C. T., Gürlek, A., Altın, T., Kılıçkap, M., Karabulut, H. G., Turhan, S., Özcan, Ö. U., Bökesoy, I., Oral, D., & Erol, Ç. (2010) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320310368190 · Cited by 11

HYPERTROPHIC CARDIOMYOPATHY: GENETIC ALTERATIONS, PATHOGENESIS AND PATHOPHYSIOLOGY

Vatutin, N. T., Тарадин, Г. Г., & Maron, M. S. (2014) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2014-5-35-42 · Cited by 11

Prognostic Significance of Myocardial Ischemia Detected by Single-Photon Emission Computed Tomography in Children with Hypertrophic Cardiomyopathy

Ziółkowska, L., Boruc, A., Sobielarska-Łysiak, D., Grzyb, A., Petryka, J., Mazurkiewicz, Ł., & Brzezińska‐Rajszys, G. (2021) · Pediatric Cardiology · doi:10.1007/s00246-021-02570-9 · Cited by 11

Associations between perfusion defects, tissue changes and myocardial deformation in hypertrophic cardiomyopathy, uncovered by a cardiac magnetic resonance segmental analysis

Bras, P. G., Rosa, S. A., Thomas, B., Fiarresga, A. J., Cardoso, I., Pereira, R., Branco, G. C., Cruz, I. R., Baquero, L., Ferreira, F., et al. (2022) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2022.03.003 · Cited by 11

Midregional pro-atrial natriuretic peptide: a novel marker of myocardial fibrosis in patients with hypertrophic cardiomyopathy

Elmas, E., Doesch, C., Fluechter, S., Freundt, M., Weiß, C., Lang, S., Kälsch, T., Haghi, D., Papassotiriou, J., Kunde, J., et al. (2010) · International journal of cardiac imaging · doi:10.1007/s10554-010-9704-2 · Cited by 11

A Clinical Approach to a Family History of Sudden Death

Tan, B. Y., & Judge, D. P. (2012) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.110.959437 · Cited by 11

Late gadolinium enhancement is common in patients with hypertrophic cardiomyopathy and no clinical risk factors for sudden cardiac death: A single center experience

Lyons, K., Dixon, L., Johnston, N., NOAD, R. L., Hamilton, A., McKeag, N., & Horan, P. G. (2013) · Cardiology Journal · doi:10.5603/cj.a2013.0115 · Cited by 11

Echocardiography as a Screening Test for Myocardial Scarring in Children with Hypertrophic Cardiomyopathy

Compton, G. L., Nield, L. E., Dragulescu, A., Benson, L. N., & Grosse‐Wortmann, L. (2016) · International Journal of Pediatrics · doi:10.1155/2016/1980636 · Cited by 11

Prognostic Role of MR Imaging in Nonischemic Myocardial Disease

Kallianos, K. G., Moraes, G. L., & Ordovas, K. G. (2014) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2014.09.004 · Cited by 10

Role of Imaging in Ablation Therapy of Ventricular Arrhythmias

Yokokawa, M., Mueller, G. C., & Bogun, F. M. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-0544 · Cited by 10

Isotropic 3D compressed sensing (CS) based sequence is comparable to 2D-LGE in left ventricular scar quantification in different disease entities

Fenski, M., Grandy, T. H., Viezzer, D., Kertusha, S., Schmidt, M., Forman, C., & Schulz‐Menger, J. (2022) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-022-02571-6 · Cited by 10

Guía de práctica clínica de la ESC 2014 sobre el diagnóstico y manejo de la miocardiopatía hipertrófica

Elliot, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagège, A. A., Lafont, A. M., Limongelli, G., Mahrholdt, H., et al. (2014) · Revista Española de Cardiología · doi:10.1016/j.recesp.2014.12.001 · Cited by 10

Determining the role of fibrosis in hypertrophic cardiomyopathy

Prinz, C., Farr, M., Laser, K. T., Esdorn, H., Piper, C., Horstkotte, D., & Faber, L. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.13.24 · Cited by 10

Multimodality imaging predictors of sudden cardiac death

Bandera, F., Baghdasaryan, L., Mandoli, G. E., & Cameli, M. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09893-z · Cited by 10

Myocardial fibrosis and quality of life in patients with non-ischemic cardiomyopathy: a cardiovascular magnetic resonance imaging study

Khan, R., Massel, D. R., Stirrat, J., Scholl, D., Wisenberg, G., Thompson, T., Drangova, M., & White, J. A. (2012) · International journal of cardiac imaging · doi:10.1007/s10554-012-0107-4 · Cited by 10

Investigation of cardiomyopathy using cardiac magnetic resonance imaging part 2: Rare phenotypes

O’Neill, A. C. (2012) · World Journal of Cardiology · doi:10.4330/wjc.v4.i5.173 · Cited by 10

Myocardial fibrosis evaluated by look–locker and late gadolinium enhancement magnetic resonance imaging in apical hypertrophic cardiomyopathy: Association with ventricular tachyarrhythmia and risk factors

Amano, Y., Takeda, M., Tachi, M., Kitamura, M., & Kumita, S. (2013) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24357 · Cited by 10

Cardiac magnetic resonance in hypertrophic cardiomyopathy: current state of the art

Kwon, D. H., & Desai, M. Y. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.108 · Cited by 10

Left atrial size and left ventricular hypertrophy correlate with myocardial fi brosis in patients with hypertrophic cardiomyopathy

Prinz, C., Hering, D., Bitter, T., Horstkotte, D., & Faber, L. (2011) · Acta cardiologica. Supplementum · doi:10.1080/ac.66.2.2071245 · Cited by 12

Myocardial Fibrosis and Regional Function in Hypertrophic Cardiomyopathy: May the Force Be with You

Carasso, S., & Rakowski, H. (2008) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2008.10.009 · Cited by 10

Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: From Experiment to Standard of Care

Faber, L. (2014) · Advances in Medicine · doi:10.1155/2014/464851 · Cited by 9

Late gadolinium enhancement location assessed by magnetic resonance and arrhythmogenic risk in hypertrophic cardiomyopathy

Barbosa, A. R., Almeida, J. G., Guerreiro, C., Teixeira, P., Ladeiras‐Lopes, R., Ferreira, N. D., Sousa, O., & Braga, P. G. S. (2020) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2019.12.009 · Cited by 9

Myocardial early systolic lengthening predicts mid-term outcomes in patients with hypertrophic cardiomyopathy

Candan, Ö., Geçmen, Ç., Kahyaoğlu, M., Şimşek, Z., Çelık, M., & Kırma, C. (2021) · International journal of cardiac imaging · doi:10.1007/s10554-021-02484-w · Cited by 9

The Prognostic Impact of Myocardial Late Gadolinium Enhancement

Panovský, R., Pleva, M., Feitová, V., Kružliak, P., Meluzı́n, J., & Kincl, V. (2014) · Cardiology in Review · doi:10.1097/crd.0000000000000002 · Cited by 9

Predicting complete heart block after alcohol septal ablation for hypertrophic cardiomyopathy using a risk stratification model and clinical tool

Karimianpour, A., Heizer, J., Leaphart, D. M., Rier, J. D., Shaji, S., Ramakrishnan, V., Nielsen, C. D., Fernandes, V. L. C., & Gold, M. R. (2021) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.29478 · Cited by 9

O diagnóstico da obstrução da via de saída do ventrículo esquerdo na cardiomiopatia hipertrófica

Mattos, B. P. E., Torres, M. A. R., Rebelatto, T. F., de Loreto, M. S., & Scolari, F. L. (2012) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2012000700013 · Cited by 9

Imaging hypertrophic heart diseases with cardiovascular MR

Proctor, R. D., Shambrook, J. S., McParland, P., Peebles, C., Brown, I. W., & Harden, S. P. (2010) · Clinical Radiology · doi:10.1016/j.crad.2010.09.008 · Cited by 9

Predictors of Atrial Fibrillation Risk in Hypertrophic Cardiomyopathy.

Tülüce, K., & Tülüce, S. Y. (2015) · PubMed Central · doi:10.4022/jafib.1200 · Cited by 9

Left ventricular twist in hypertrophic cardiomyopathy

Candan, Ö., Geçmen, Ç., Kalaycı, A., Bayam, E. M., Güner, A., Gündüz, S., Çerşit, S., & Ozkan, M. (2017) · Herz · doi:10.1007/s00059-017-4633-7 · Cited by 9

Late gadolinium enhancement gray zone in patients with hypertrophic cardiomyopathy. Comparison of different gray zone definitions

Śpiewak, M., Małek, Ł. A., Chojnowska, L., Miśko, J., Petryka, J., Kłopotowski, M. M., Miłosz, B., Polańska, M., & Rużyłło, W. (2010) · International journal of cardiac imaging · doi:10.1007/s10554-010-9620-5 · Cited by 9

Cardiovascular magnetic resonance of cardiomyopathies

Alpendurada, F., O’Hanlon, R., & Prasad, S. K. (2008) · Current Cardiology Reports · doi:10.1007/s11886-009-0010-3 · Cited by 9

The role of late gadolinium enhancement cardiovascular magnetic resonance in the assessment of congenital and acquired heart disease

Babu‐Narayan, S. V. (2009) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2009.10.006 · Cited by 8

Myocardial contrast echocardiography for the distinction of hypertrophic cardiomyopathy from athlete's heart and hypertensive heart disease

Indermuehle, A. (2009) · Swiss Medical Weekly · doi:10.4414/smw.2009.12775 · Cited by 8

Comparison between maximal left ventricular wall thickness and left ventricular mass in patients with hypertrophic cardiomyopathy.

Śpiewak, M., Chojnowska, L., Małek, Ł. A., Miłosz, B., Petryka, J., Żabicka, M., Kłopotowski, M. M., Dąbrowski, M., Miśko, J., & Rużyłło, W. (2010) · PubMed · Cited by 8

The Clinical Prognosis of Presence and Location of Late Gadolinium Enhancement by Cardiac Magnetic Resonance Imaging in Patients with Hypertrophic Cardiomyopathy: a Single-Center Cohort Study

Li, X., Lai, L. F., Luo, R., Yang, H., Ma, H., Yang, Z., Zhao, S., SU, W. W., & Hua, W. (2021) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-021-10107-x · Cited by 8

Hypertrophic cardiomyopathy in the Saudi Arabian population: Clinical and echocardiographic characteristics and outcome analysis

Ahmed, W., Akhtar, N., Bech‐Hanssen, O., Al‐Mahdi, B., Otaibi, T. A., & Fadel, B. M. (2013) · Journal of the Saudi Heart Association · doi:10.1016/j.jsha.2013.08.003 · Cited by 8

Left ventricular diastolic function assessed with cardiovascular magnetic resonance imaging and exercise capacity in patients with non-obstructive hypertrophic cardiomyopathy

Małek, Ł. A., Miśko, J., Kłopotowski, M. M., Chojnowska, L., Śpiewak, M., Miłosz, B., Mączyńska, R., Piotrowicz, E., & Rużyłło, W. (2009) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-11-s1-p238 · Cited by 8

Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy

Desai, M. Y., Dhillon, A. S., & To, A. C. Y. (2010) · Current Cardiology Reports · doi:10.1007/s11886-010-0149-y · Cited by 8

Imaging techniques in the evaluation and management of hypertrophic cardiomyopathy

Kelley-Hedgepeth, A., & Maron, M. S. (2009) · Current Heart Failure Reports · doi:10.1007/s11897-009-0020-x · Cited by 8

Cardiac Magnetic Resonance Imaging for Sudden Cardiac Death. Much More Than Another Method to Measure LVEF

Schmidt, A., Romano, M. M. D., Maciel, B. C., & Marin‐Neto, J. A. (2013) · Current Cardiovascular Imaging Reports · doi:10.1007/s12410-013-9231-3 · Cited by 8

Subclinical Myocardial Disease in Heart Failure Detected by CMR

Ohyama, Y., Volpe, G. J., & Lima, J. A. C. (2014) · Current Cardiovascular Imaging Reports · doi:10.1007/s12410-014-9269-x · Cited by 8

Right ventricle myectomy

Borisov, K. V. (2017) · Annals of Cardiothoracic Surgery · doi:10.21037/acs.2017.07.10 · Cited by 8

Risk stratification in pediatric hypertrophic cardiomyopathy: Insights for bridging the evidence gap?

Nakano, S. J., & Menon, S. C. (2018) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2018.03.001 · Cited by 8

Role of imaging in evaluation of sudden cardiac death risk in hypertrophic cardiomyopathy

Geske, J. B., & Ommen, S. R. (2015) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000202 · Cited by 8

Assessing Risk for Ventricular Tachyarrhythmias and Sudden Cardiac Death

Wu, K. C. (2012) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.111.971135 · Cited by 8

Ambulatory electrocardiography, heart rate variability, and pharmacologic stress testing in cats with subclinical hypertrophic cardiomyopathy

Walker, A. L., Ueda, Y., Crofton, A. E., Harris, S. P., & Stern, J. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-05999-x · Cited by 7

Novel MYBPC3 Mutations in Indian Population with Cardiomyopathies

Rani, D. S., Kasala, A., Dhandapany, P. S., Muthusami, U., Kunnoth, S., Rathinavel, A., Ayapati, D. R., & Kumarasamy Thangaraj, K. (2023) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s407179 · Cited by 7

Incremental Value of Live/Real Time Three‐Dimensional Transthoracic Echocardiography over Two‐Dimensional Echocardiography in Hypertrophic Cardiomyopathy with Mid‐Ventricular Obstruction and Apical Aneurysm

Thind, M., Joson, M., Gaba, S., Elsayed, M., Bulur, S., Güvenç, T. S., Elguindy, M., & Nanda, N. C. (2014) · Echocardiography · doi:10.1111/echo.12848 · Cited by 7

Impact of cardiac magnetic resonance imaging in non-ischemic cardiomyopathies

Kalisz, K. R. (2016) · World Journal of Cardiology · doi:10.4330/wjc.v8.i2.132 · Cited by 7

A SYSTEMATIC REVIEW OF THE OCCURRENCE OF PATHOLOGICAL ARRHYTHMIA IN INDIVIDUALS WHO CAME TO THE EMERGENCY ROOM WITH THE DIAGNOSIS OF CARDIAC ARRHYTHMIA

Ullah, R. A. H. D. K. (2022) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.7351836

Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy

McLellan, A. J. A., Ellims, A., Prabhu, S., Voskoboinik, A., Iles, L., Hare, J., Kaye, D. M., Macciocca, I., Mariani, J. A., Kalman, J. M., et al. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12948 · Cited by 71

176-72: Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates with Ventricular Tachycardia in Patients with Hypertrophic Cardiomyopathy

McLellan, A. J. A., Ellims, A., Prabhu, S., Voskoboinik, A., Iles, L., Hare, J., Kaye, D. M., Macciocca, I., Mariani, J. A., Kalman, J. M., et al. (2016) · EP Europace · doi:10.1093/europace/18.suppl_1.i135b · Cited by 2

Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study

Kwon, D. H., Setser, R. M., Popović, Z., Thamilarasan, M., Sola, S., Schoenhagen, P., Garcia, M. J., Flamm, S. D., Lever, H. M., & Desai, M. Y. (2008) · International journal of cardiac imaging · doi:10.1007/s10554-008-9292-6 · Cited by 123

Fibrotic Changes in the Myocardium as an Independent Predictor of Rhythm Disturbance in Patients with Hypertrophic Cardiomyopathy

Базылев, В. В., Карпухин, В. Г., Mikulyak, A. I., & Palkova, V. A. (2017) · Medical Visualization · doi:10.24835/1607-0763-2017-6-19-24 · Cited by 1